APA

Havrilesky L. J., Yang J., Lee P. S., Secord A. A., Ehrisman J. A., Davidson B., Berchuck A., Darcy K. M., Maxwell G. L. & Reed S. D. (20200526). Patient preferences for attributes of primary surgical debulking versus neoadjuvant chemotherapy for treatment of newly diagnosed ovarian cancer. : Cancer.

Chicago

Havrilesky Laura J, Yang Jui-Chen, Lee Paula S, Secord Angeles Alvarez, Ehrisman Jessie A, Davidson Brittany, Berchuck Andrew, Darcy Kathleen M, Maxwell G Larry and Reed Shelby D. 20200526. Patient preferences for attributes of primary surgical debulking versus neoadjuvant chemotherapy for treatment of newly diagnosed ovarian cancer. : Cancer.

Harvard

Havrilesky L. J., Yang J., Lee P. S., Secord A. A., Ehrisman J. A., Davidson B., Berchuck A., Darcy K. M., Maxwell G. L. and Reed S. D. (20200526). Patient preferences for attributes of primary surgical debulking versus neoadjuvant chemotherapy for treatment of newly diagnosed ovarian cancer. : Cancer.

MLA

Havrilesky Laura J, Yang Jui-Chen, Lee Paula S, Secord Angeles Alvarez, Ehrisman Jessie A, Davidson Brittany, Berchuck Andrew, Darcy Kathleen M, Maxwell G Larry and Reed Shelby D. Patient preferences for attributes of primary surgical debulking versus neoadjuvant chemotherapy for treatment of newly diagnosed ovarian cancer. : Cancer. 20200526.